<\/p>\n
NEW FILINGS<\/p>\n
Company: AFC Gamma, Inc.
\nSymbol: AFCG
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: AFC Gamma, Inc. is a commercial real estate finance company founded in July 2020 by a veteran team of investment professionals.
\nUnderwriter(s): JMP Securities, Ladenburg Thalmann, Seaport Global
\nCo-Manager: Lake Street
\nFiled: 1-22-21
\nListed Cash Raise: $115m<\/p>\n
Company: Caliber Home Loans, Inc.
\nSymbol: HOMS
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a proven leader in the U.S. mortgage market with a uniquely diversified, customer-centric, purchase-focused platform.
\nUnderwriter(s): Credit Suisse, Goldman Sachs, Barclays, BofA Securities, Citigroup, UBS Investment Bank, Wells Fargo Securities
\nCo-Manager: Deutsche Bank Securities, Keefe, Bruyette & Woods, Drexel Hamilton, Loop Capital Markets, R. Seelaus & Co., LLC, Tigress Financial Partners
\nFiled: 1-21-21
\nListed Cash Raise: $100m
\nPostponed in October 2020<\/p>\n
Company: Bioventus Inc..
\nSymbol: BVS
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body\u2019s natural healing process.
\nUnderwriter(s): Morgan Stanley, JP Morgan, Goldman Sachs
\nCo-Manager: Canaccord Genuity
\nFiled: 1-20-21
\nListed Cash Raise: $100m<\/p>\n
Company: Signify Health, Inc..
\nSymbol: SGFY
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs.
\nUnderwriter(s): Goldman Sachs, JP Morgan, Barclays, Deutsche Bank Securities, BofA Securities, UBS Investment Bank, Baird, Piper Sandler, William Blair
\nFiled: 1-19-21
\nListed Cash Raise: $100m<\/p>\n
Company: NexImmune, Inc.
\nSymbol: NEXI
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body\u2019s own T cells to generate a specific, potent and durable immune response that mimics natural biology.
\nUnderwriter(s): Barclays, Cantor, Raymond James, Allen & Co.
\nFiled: 1-19-21
\nListed Cash Raise: $86.25m<\/p>\n
Company: Adagene Inc.
\nSymbol: ADAG
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, Jefferies
\nCo-Manager: China Renaissance
\nFiled: 1-19-21
\nListed Cash Raise: $100m<\/p>\n
Company: Cloopen Group Holding Limited
\nSymbol: RAAS
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are the largest multi-capability cloud-based communications solution provider in China, as measured by revenues in 2019, according to the CIC report(1)
\nUnderwriter(s): Goldman Sachs, Citigroup, CICC
\nFiled: 1-19-21
\nListed Cash Raise: $100m<\/p>\n
Company: Telus International (Cda), Inc.
\nSymbol: TINT
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a leading digital customer experience innovator that designs, builds and delivers next-generation solutions for global and disruptive brands.
\nUnderwriter(s): JP Morgan, Morgan Stanley, Barclays, BofA Securities, CIBC Capital, Citigroup, Credit Suisse, RBC Capital, Baird, BMO Capital
\nCo-Manager(s): Scotiabank, TD, Wells Fargo, William Blair, MUFG, National Bank of Canada Financial Markets
\nFiled: 1-19-21
\nListed Cash Raise: $100m<\/p>\n
Company: Decipher Biosciences, Inc.
\nSymbol: DECI
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers.
\nUnderwriter(s): Evercore ISI, Wells Fargo
\nCo-Manager(s): Canaccord Genuity, BTIG
\nFiled: 1-19-21
\nListed Cash Raise: $100m<\/p>\n
Company: Bolt Therapeutics, Inc.
\nSymbol: BOLT
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
\nUnderwriter(s): Morgan Stanley, SVB Leerink, Stifel, Guggenheim Securities
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Vor Biopharma, Inc.
\nSymbol: VOR
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: The mission of Vor Biopharma is to develop transformative treatments for patients suffering from hematological malignancies.
\nUnderwriter(s): Goldman Sachs, Evercore ISI, Barclays, Stifel
\nFiled: 1-15-21
\nListed Cash Raise: $150m<\/p>\n
Company: Terns Pharmaceuticals, Inc.
\nSymbol: TERN
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
\nUnderwriter(s): JP Morgan, Goldman Sachs, Cowen
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Angion Biomedica Corp.
\nSymbol: ANGN
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.
\nUnderwriter(s): Cowen, Stifel
\nFiled: 1-15-21
\nListed Cash Raise: $75m
\nPostponed in October 2015<\/p>\n
Company: PurposeBuilt Brands, Inc.
\nSymbol: PBLT
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: PurposeBuilt Brands is a high-growth portfolio of category-leading, efficacy-driven specialty cleaning and disinfection brands with a 40-year track record of successive annual sales growth.
\nUnderwriter(s): Barclays, Morgan Stanley, Goldman Sachs, Baird, BofA Securities, Credit Suisse, UBS Investment Bank
\nCo-Manager: Academy Securities, Blaylock Van LLC, R. Seelaus & Co., Ramirez & Co., TCG Capital
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Lucira Health, Inc.
\nSymbol: LHDX
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.
\nUnderwriter(s): BofA Securities, William Blair
\nCo-Manager: LifeSci Capital
\nFiled: 1-15-21
\nListed Cash Raise: $115m<\/p>\n
Company: Apria, Inc.
\nSymbol: APR
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a leading provider of integrated home healthcare equipment and related services in the United States.
\nUnderwriter(s): Citigroup, Goldman Sachs, BofA Securities, JP Morgan
\nCo-Manager: Piper Sandler, Fifth Third Securities, TD Securities
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: LumiraDx Limited
\nSymbol: LMDX
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a next-generation point of care, or POC, diagnostic company addressing the current limitations of legacy POC systems by bringing lab-comparable performance to the POC in minutes, on a single instrument with a low cost of ownership.
\nUnderwriter(s): Jefferies, SVB Leerink, Evercore ISI, Raymond James
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Immunocore Holdings plc
\nSymbol: IMCR
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, infectious and autoimmune.
\nUnderwriter(s): Goldman Sachs, JP Morgan, Jefferies
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Pharvaris B.V.
\nSymbol: PHVS
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.
\nUnderwriter(s): Morgan Stanley, BofA Securities, SVB Leerink
\nCo-Manager: Oppenheimer, Kempen & Co.
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Sensei Biotherapeutics, Inc.
\nSymbol: SNSE
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are an immunotherapy company engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer
\nUnderwriter(s): Citigroup, Piper Sandler, Berenberg
\nCo-Manager: Oppenheimer
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Company: Bumble, Inc.
\nSymbol: BMBL
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: The Bumble brand was built with women at the center\u2014where women make the first move.
\nUnderwriter(s): Goldman Sachs, Citigroup, Morgan Stanley, JP Morgan
\nFiled: 1-15-21
\nListed Cash Raise: $100m<\/p>\n
Terms Added<\/p>\n
Company: Shoals Technology Group, Inc.
\nSymbol: SHLS
\nDescription: They are a leading provider of electrical balance of system or \u201cEBOS\u201d solutions for solar energy projects in the United States.
\nShares: 50 million
\nPrice Range: $19.00-$21.00
\nMarket Cap: TBD
\nTrade Date: Wednesday, 1\/27
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Guggenheim Securities, UBS Investment Group, Morgan Stanley, Barclays, Credit Suisse
\nCo-Manager(s): Cowen, Oppenheimer
\nTerms Added: 1-19-21<\/p>\n
Company: Qualtrics International Inc.
\nSymbol: XM
\nDescription: They have pioneered a new category of software, experience management, or XM, which enables organizations to succeed in today\u2019s experience economy.
\nShares: 49.2 million
\nPrice Range: $22.00-$26.00
\nMarket Cap: $11.1b-$13.1b
\nTrade Date: Thursday, 1\/28
\nUnderwriter(s): Morgan Stanley, J.P. Morgan, BofA Securities, Barclays, Deutsche Bank Securities, Goldman Sachs, HSBC, Citigroup, BMO Capital Markets, Truist Securities, Canaccord Genuity, Evercore ISI, JMP Securities, Oppenheimer & Co., Piper Sandler, Raymond James, William Blair
\nCo-Managers: Loop Capital Markets, Ramirez & Co., R. Seelaus & Co. LLC.
\nTerms Added: 1-19-21<\/p>\n
Company: Ortho Clinical Diagnostics Holdings plc
\nSymbol: OCDX
\nShares: 70 million
\nPrice Range: $20.00-$23.00
\nMarket: Cap: 4.35b-$5.0b
\nTrade Date: Thursday, 1\/28
\nDescription: They are a pure-play in vitro diagnostics (\u201cIVD\u201d) business driven by our credo, \u201cBecause Every Test is A Life.\u201d
\nUnderwriter(s): J.P. Morgan, BofA Securities, Goldman Sachs, Barclays, Morgan Stanley, Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler
\nCo-Manager(s): ING, Macquarie Capital, , Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez & Co., Siebert Williams Shank
\nTerms Added: 1-19-21<\/p>\n
Company: Vinci Partners Investments Ltd.
\nSymbol: VINP
\nShares: 13.8 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $888m-$1.0bn
\nTrade Date: Thursday, 1\/28
\nDescription: Vinci Partners is a leading alternative investment platform in Brazil, established in 2009.
\nUnderwriters: JP Morgan, Goldman Sachs, BTG Pactual, Itau BBA, BofA Securities, Credit Suisse, UBS Investment Bank
\nTerms Added: 1-19-21<\/p>\n
Company: ZIM Integrated Shipping Services Ltd.
\nSymbol: ZIM
\nDescription: They are a global, asset-light container liner shipping company with leadership positions in niche markets where we believe we have distinct competitive advantages that allow us to maximize our market position and profitability.
\nShares: 17.5 million
\nPrice Range: $16.00-$19.00
\nMarket Cap: $1.6b-$1.9b
\nTrade Date: Thursday, 1\/28
\nTerms Added: 1-19-21<\/p>\n
Company: Southeastern Grocers, Inc.
\nSymbol: SEGR
\nDescription: They are a leading regional food retailer based on revenue and number of stores we operate with a long-standing history in the Southeastern United States, serving highly attractive markets throughout Florida, Georgia, Alabama, Louisiana and Mississippi.
\nShares: 8.9 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $607m-$694m
\nTrade Date: Friday, 1\/29
\nUnderwriter(s): BofA Securities, Goldman Sachs
\nCo-Manager(s): Deutsche Bank Securities, BMO Capital Markets, Truist Securities, Wells Fargo Securities
\nTerms Added: 1-21-21<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,2058,1536],"tags":[],"class_list":["post-17009","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=17009"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17009\/revisions"}],"predecessor-version":[{"id":17010,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17009\/revisions\/17010"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=17009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=17009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=17009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}